217 related articles for article (PubMed ID: 11115351)
21. K-ras-2 topographic genotyping of pancreatic adenocarcinoma.
Finkelstein SD; Przygodzki R; Pricolo VE; Sayegh R; Bakker A; Swalsky PA; Keller G
Arch Surg; 1994 Apr; 129(4):367-72; discussion 372-3. PubMed ID: 8154963
[TBL] [Abstract][Full Text] [Related]
22. Pancreaticoduodenectomy with right-oblique posterior dissection of superior mesenteric nerve plexus is logical procedure for pancreatic cancer with extrapancreatic nerve plexus invasion.
Nagakawa Y; Hosokawa Y; Osakabe H; Sahara Y; Takishita C; Nakajima T; Hijikata Y; Kasahara K; Kazuhiko K; Saito K; Tsuchida A
Hepatogastroenterology; 2014; 61(136):2371-6. PubMed ID: 25699385
[TBL] [Abstract][Full Text] [Related]
23. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
24. Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma.
Ando N; Nakao A; Nomoto S; Takeda S; Kaneko T; Kurokawa T; Nonami T; Takagi H
Pancreas; 1997 Nov; 15(4):374-8. PubMed ID: 9361091
[TBL] [Abstract][Full Text] [Related]
25. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Tada M; Omata M; Ohto M
Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
[TBL] [Abstract][Full Text] [Related]
26. K-ras mutation at codon 12 in stage I pancreatic adenocarcinoma: analysis by laser capture microdissection and direct sequencing.
Chang MC; Chang YT; Wu MS; Shun CT; Tien YW; Lin JT
J Formos Med Assoc; 2001 May; 100(5):352-4. PubMed ID: 11432318
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
[TBL] [Abstract][Full Text] [Related]
29. Nerve plexus invasion in pancreatic cancer: spread patterns on histopathologic and embryological analyses.
Makino I; Kitagawa H; Ohta T; Nakagawara H; Tajima H; Ohnishi I; Takamura H; Tani T; Kayahara M
Pancreas; 2008 Nov; 37(4):358-65. PubMed ID: 18972625
[TBL] [Abstract][Full Text] [Related]
30. Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
Dergham ST; Dugan MC; Arlauskas P; Du W; Vaitkevicius VK; Crissman JD; Sarkar FH
Int J Pancreatol; 1997 Jun; 21(3):225-34. PubMed ID: 9322121
[TBL] [Abstract][Full Text] [Related]
31. Precise anatomical resection based on structures of nerve and fibrous tissue around the superior mesenteric artery for mesopancreas dissection in pancreaticoduodenectomy for pancreatic cancer.
Nagakawa Y; Yi SQ; Takishita C; Sahara Y; Osakabe H; Kiya Y; Yamaguchi H; Miwa Y; Sato I; Tsuchida A
J Hepatobiliary Pancreat Sci; 2020 Jun; 27(6):342-351. PubMed ID: 32048456
[TBL] [Abstract][Full Text] [Related]
32. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
[TBL] [Abstract][Full Text] [Related]
33. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
34. Unique K-ras mutational pattern in pancreatic adenocarcinoma from Taiwanese patients.
Wang JY; Lian ST; Chen YF; Yang YC; Chen LT; Lee KT; Huang TJ; Lin SR
Cancer Lett; 2002 Jun; 180(2):153-8. PubMed ID: 12175546
[TBL] [Abstract][Full Text] [Related]
35. C-Ki-ras mutations in peripheral blood of pancreatic cancer patients: a marker for early tumor metastasis.
Mohiuddin M; Ahmed MM; Venkatasubbarao K
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):161-6. PubMed ID: 12118546
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
[TBL] [Abstract][Full Text] [Related]
37. A case of small pancreatic cancer diagnosed by serial follow-up studies promptly by a positive K-ras point mutation in pure pancreatic juice.
Ochi K; Hasuoka H; Mizushima T; Matsumura N; Harada H
Am J Gastroenterol; 1998 Aug; 93(8):1366-8. PubMed ID: 9707068
[TBL] [Abstract][Full Text] [Related]
38. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
39. Patterns of genetic alterations in pancreatic cancer: a pooled analysis.
Blanck HM; Tolbert PE; Hoppin JA
Environ Mol Mutagen; 1999; 33(2):111-22. PubMed ID: 10217065
[TBL] [Abstract][Full Text] [Related]
40. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
